| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/23/2003 | EP1329522A1 Method of detecting norwalk-like virus (gi) |
| 07/23/2003 | EP1329509A2 Method for generating a subtracted cDNA library and uses of the generated library |
| 07/23/2003 | EP1329508A1 Novel g protein-coupled receptor protein and dna thereof |
| 07/23/2003 | EP1329507A1 Artificial protein having potentiated immunogenicity of epitope |
| 07/23/2003 | EP1329504A1 Nucleic acid of novel human kinesin-associated gene, protein encoded by the nucleic acid, peptide fragment thereof and anticancer agents comprising the nucleic acid and the like |
| 07/23/2003 | EP1329499A2 Growth factor-responsive progenitor cells which can be proliferated in vitro |
| 07/23/2003 | EP1329462A1 Method of producing human serum albumin involving heating step |
| 07/23/2003 | EP1329461A1 Method of eliminating human serum albumin polymers |
| 07/23/2003 | EP1329460A1 Method of monomerizing human serum albumin polymers |
| 07/23/2003 | EP1329459A2 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon |
| 07/23/2003 | EP1329458A2 Peptides that lower blood glucose levels |
| 07/23/2003 | EP1329227A1 Diagnostic conjugate useful for intercellular imaging and for differentiating between tumor- and non-tumor cells |
| 07/23/2003 | EP1328811A2 Hcv mosaic antigen composition |
| 07/23/2003 | EP1328807A2 Use of vanilloid 4 receptor and antagonists or agonists thereof for treating diseases associated with pain |
| 07/23/2003 | EP1328662A2 Flea peritrophin nucleic acid molecules, proteins and uses thereof |
| 07/23/2003 | EP1328661A2 Estrogen receptor alpha variants and methods of detection thereof |
| 07/23/2003 | EP1328653A2 Highly expressible genes |
| 07/23/2003 | EP1328652A1 Non-human transgenic animal expressing ca-ahr |
| 07/23/2003 | EP1328651A2 Monocotyledon plant cells and plants which synthesise modified starch |
| 07/23/2003 | EP1328650A2 Plant cell death system |
| 07/23/2003 | EP1328649A2 Plant cell death system |
| 07/23/2003 | EP1328641A2 Polynucleotides isolated from e. coli of nature b2/d+ a-, and uses thereof |
| 07/23/2003 | EP1328640A2 Polypeptides and polynucleotides from haemophilus influenzae and their use |
| 07/23/2003 | EP1328638A2 Secreted alpha-helical protein zlmda24 |
| 07/23/2003 | EP1328637A2 Regulation of human secretin receptor-like gpcr |
| 07/23/2003 | EP1328636A2 Nucleic acids and polypeptides |
| 07/23/2003 | EP1328635A2 Compositions and methods relating to lung specific genes |
| 07/23/2003 | EP1328634A2 Genes expressed in the cell cycle |
| 07/23/2003 | EP1328633A2 Human ion channel proteins and polynucleotides encoding the same |
| 07/23/2003 | EP1328632A2 C1q-related factor, homologous polypeptides and therapeutic uses thereof |
| 07/23/2003 | EP1328631A2 Her-2/neu fusion proteins |
| 07/23/2003 | EP1328630A2 Secreted proteins |
| 07/23/2003 | EP1328628A2 Method for exposing peptides and polypeptides on the cell surface of bacteria |
| 07/23/2003 | EP1328625A2 Dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 07/23/2003 | EP1328624A2 B7-like molecules and uses thereof |
| 07/23/2003 | EP1328619A1 Human tuberoinfundibular peptide of 39 residues |
| 07/23/2003 | EP1328549A1 Human prostate specific g-protein receptor hpraj70 |
| 07/23/2003 | EP1328548A2 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design |
| 07/23/2003 | EP1328546A2 Cyclic peptides, method for preparing same and use as angiogenesis inhibitor or activator |
| 07/23/2003 | EP1328545A1 Human gene critical to fertility |
| 07/23/2003 | EP1328544A1 Transgenic plants |
| 07/23/2003 | EP1328543A2 Nucleic acids and proteins from streptococcus groups a & b |
| 07/23/2003 | EP1328542A1 Von willebrand factor-binding proteins from staphylococci |
| 07/23/2003 | EP1328541A2 Basb207 polypeptides and polynucleotides from nontypeable haemophilus influenzae |
| 07/23/2003 | EP1328540A2 Immunoreactive peptidic ctl epitopes of human cytomegalovirus pp150 |
| 07/23/2003 | EP1328539A1 Vegf peptides and their use for inhibiting angiogenesis |
| 07/23/2003 | EP1328297A2 The function of a haptoglobin-haemoglobin receptor and the uses thereof |
| 07/23/2003 | EP1328293A2 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth |
| 07/23/2003 | EP1328290A2 Expression, preparation, uses, and sequence of recombinantly-derived soluble hla-g |
| 07/23/2003 | EP1328289A2 Oxidized proteins, their biological activity, and therapeutic and diagnostic measures, which are derived from the active mechanism, from the use of these proteins or from the inhibition thereof |
| 07/23/2003 | EP1328287A1 Compositions and methods for wt1 specific immunotherapy |
| 07/23/2003 | EP1328234A4 Methods for treating cystic fibrosis |
| 07/23/2003 | EP1328234A1 Methods for treating cystic fibrosis |
| 07/23/2003 | EP1328151A2 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer |
| 07/23/2003 | EP1254260A4 Methods for diagnosing and treating heart disease |
| 07/23/2003 | EP1250419A4 Isolated polynucleotide encoding a novel phosphate transporter in plants and a method of modulating phosphate uptake in plants |
| 07/23/2003 | EP1154785B1 Inhibitors for use in hemostasis and immune function |
| 07/23/2003 | EP1079818B1 Composition comprising il-18 and topotecan for treatment and/or prevention of cancer |
| 07/23/2003 | EP1042459A4 Bifunctional molecules |
| 07/23/2003 | EP1019078B1 Use of cartilage oligomeric matrix protein for the treatment of rheumatoid arthritis |
| 07/23/2003 | EP1011716B1 Neuromedin b receptor antagonists |
| 07/23/2003 | EP1007682A4 Novel nucleic acid molecules and uses therefor |
| 07/23/2003 | EP0951294B1 Method of producing concentrated non-buffered solutions of fibronectin |
| 07/23/2003 | EP0871665B1 Insulin derivatives |
| 07/23/2003 | EP0814827B1 Vascular endothelial growth factor-b |
| 07/23/2003 | EP0776367B1 Dna encoding turkey hypothalamic vasoactive intestinal peptide |
| 07/23/2003 | EP0756630B1 Recombinant pgp3, methods of preparation and use in diagnosis and therapy |
| 07/23/2003 | EP0743958B1 Avidin-biotin immunoconjugates |
| 07/23/2003 | EP0714408B1 Tryptase inhibitor |
| 07/23/2003 | EP0643770B1 Helicobacter pylori cytotoxin associated immunodominant antigen useful for vaccines and diagnostics |
| 07/23/2003 | EP0602113B1 Callus-specific promoters |
| 07/23/2003 | EP0586607B1 HEREGULINS (HRGs), BINDING PROTEINS OF P185?erb2 |
| 07/23/2003 | CN1432066A Corynebacterium glutamicum nucleotide sequences coding for glbO gene |
| 07/23/2003 | CN1432065A Bacterial insecticidal proteins |
| 07/23/2003 | CN1432064A Bi-functional cancer treatment agents |
| 07/23/2003 | CN1432062A Novel protein and gene encoding same |
| 07/23/2003 | CN1432024A Immunodominant acetylcholine receptor alpha subunit peptides |
| 07/23/2003 | CN1432021A Process for preparing coagulants for water treatment |
| 07/23/2003 | CN1431911A Transgenically produced decorin |
| 07/23/2003 | CN1431309A Gene of encoded plant transcription factor |
| 07/23/2003 | CN1431307A Derivatization growth factor 4 of human liver cancer, its coding sequence, preparing method and usage |
| 07/23/2003 | CN1431306A Derivatization growth factors 5 of human liver cancer, its coding sequence, preparing method and usage |
| 07/23/2003 | CN1115414C Virus carrier used for gene therapy |
| 07/23/2003 | CN1115413C Synthetic leader peptide sequences |
| 07/23/2003 | CN1115412C Pro-Urokinase mutants |
| 07/22/2003 | USRE38202 Antibodies specific for a haemostatic protein, their use for isolating protein, haemostatic compositions devoid of proteolytic cleavage products of the protein |
| 07/22/2003 | US6596930 Modification of cereal grain hardness via expression of puroindoline protein |
| 07/22/2003 | US6596925 Compositions and methods for the modification of gene expression |
| 07/22/2003 | US6596923 Methods and compositions to identify swine genetically resistant to F18 E. coli associated diseases |
| 07/22/2003 | US6596855 Polynucleotide encoding CZF-1 protein |
| 07/22/2003 | US6596854 Human translation protein; for use in the treatment of cancer |
| 07/22/2003 | US6596853 Nucleotide sequences coding polypeptide for use in the treatment of cancer and prevention of infections |
| 07/22/2003 | US6596852 Antibodies that bind the cytokine designated LERK-5 |
| 07/22/2003 | US6596847 Tissue factor protein variants |
| 07/22/2003 | US6596778 β-endorphin peptides for treating muscle-wasting diseases |
| 07/22/2003 | US6596691 Administering therapeutically effective amount of bactericidal/permeability-increasing protein product to a human suffering from meningococcemia |
| 07/22/2003 | US6596690 Stimulating proliferation of the bone marrow cell or protecting the bone marrow cell from the toxicity caused by chemotherapy or irradiation |
| 07/22/2003 | US6596689 Therapeutic method using fucose-containing proteoglycan or acidic glycan |
| 07/22/2003 | US6596688 Method for promoting hematopoiesis |
| 07/22/2003 | US6596687 Cell adhesion inhibitors |